Myelofibrosis Diagnosis And Risk Stratification

Expert panelists Harry P. Erba, MD, PhD; Jamile M. Shammo, MD, FASCP, FACP; Ruben A. Mesa, MD, FACP; Srdan Verstovsek, ...

Risk stratification

Panelists define the prognosis and

An overview regarding the evolution of prognostic scoring systems used to

Harry Erba, MD, PhD, describes the typical presentation and the

Discussion on the clinical presentation,

Discussion of

What is

Daniel DeAngelo, MD, PhD, discusses the

Moshe Talpaz, MD, reviews the

A review of

Myelofibrosis

Harry Erba, MD, PhD, discusses how

Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the

Myelofibrosis

Physician Assistant Amber Essenmacher PA-C, MMS specializes in helping people with rare, chronic blood cancers called ...

The average survival rate for patients with

In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August ...

Clinical outcomes and quality of life in patients with MPN and MDS continue to be enhanced as cytogenetic analysis and novel ...

What is involved in determining low